In vivo expression of the insulin-like growth factor-I (IGF-I) receptor in congenital pigmented nevi

Journal of Cutaneous Pathology

Volumn 23, Issue 1, 1996, Pages 19-24

  Hodak, E ^a,c   Gottlieb, A B ^a   Colen, S ^b   Anzilotti, M ^a   Krueger, J G ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY KI 67; SOMATOMEDIN C RECEPTOR;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL SURFACE; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; KERATINOCYTE; MELANOCYTE; MELANOMA CELL; NEVUS CELL; PIGMENTED NEVUS; PRESCHOOL CHILD; RISK;

CELL DIVISION; CHILD, PRESCHOOL; HUMANS; INFANT; NEVUS, PIGMENTED; RECEPTOR, IGF TYPE 1; SKIN NEOPLASMS;

EID: 0030053247     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1996.tb00772.x     Document Type: Article

References (32)

1. Czech MP. Signal transmission by the insulin-like growth factors. Cell 1989: 59: 235.
2. Massage J, Czech MP. The subunit of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem 1982: 257: 5038.
3. Ullrich A, Gray A, Tam AW, et al. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificy. Eur Mol Biol Organ J 1986: 5: 2503.
4. Krane JF, Murphy DP, Carter DM, Krueger JG. Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor. J Invest Dermatol 1991: 96: 419.
5. Krane JF, Gottlieb AB, Carter DM, Krueger JG. The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis but is differentially regulated from the epidermal growth factor receptor. J Exp Med 1992: 175: 1081.
6. Hodak E, Gottlieb AB, Anzilloti M, Krueger JG. The IGF-I receptor is widely expressed by distinct epithelial cell types in human skin. Correlation of increased expression with regenerative epidermal growth. J Invest Dermatol (accepted for publication).
7. Herlyn M, Mancianti ML, Jambrosie J, Bolen JB, Koprowski H. Regulatory factors that determine growth and phenotype of normal human melanocytes. Exp Cell Res 1988: 179: 322.
8. Mancianti ML, Györfi T, Shih I-M, et al. Growth regulation of cultured human nevus cells. J Invest Dermatol 1993: 100: 2815.
9. Rodeck U, Herlyn M, Menssen HD, Furlanetto RW, Koprowski H. Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors. Int J Cancer 1987: 40: 687.
10. Stracke ML, Engel JD, Wilson LW, Rechler MM, Liotta LA, Schiffman E. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J Biol Chem 1989: 264: 21544.
11. Rhodes AR. The risk of malignant melanoma arising in congenital melanocytic nevi. Am J Dermatopathol 1984: 6(suppl 1): 184.
12. Kopf AW, Bart RS, Hennessey P. Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol 1979: 1: 123.
13. Kull FC Jr, Jacobs S, Su Y-F, Svoboda ME, Van Wyk JJ, Cuatrecassas P. Monoclonal antibodies to receptors for insulin and somatomedin-D. J Biol Chem 1983: 258: 6561.
14. Jacobs S, Cook S, Svoboda ME, Van Wyk JJ. Interaction of the monoclonal antibodies alpha-IR3 with insulin and somatomedin-C receptors. Endocrinology 1986: 118: 223.
15. Catanese VM, Grigorescu F, King GL, Kahn CR. The human erythrocyte insulin-like growth factor I receptor: Characterization and demonstration of ligand-stimulated autophosphorylation. J Clin Endocrinol Metab 1986: 62: 692.
16. Bruno S, Darzynkiewicz Z. Cell cycle dependent expression and stability of the nuclear protein detected by Ki67 antibody in HL-60 cells. Cell Proliferation 1992: 25: 31.
17. Smolle J, Soyer HP, Kerl H. Proliferative activity of cutaneous melanocytic tumors defined by Ki67 monoclonal antibody. Am J Dermatopathol 1989: 11: 301.
18. Soyer HP. Immunostaining in melanocytic skin tumors. Correlation with histologic parameters. J Cutan Pathol 1991: 18: 264.
19. Rosenfeld RG, Dollar LA. Characterization of the somatomedin C-insulin-like growth factor I(SM-C/IGF-I) receptor on cultured human fibroblast monolayer: regulation of receptor concentrations by SM-C/IGF-I and insulin. J Clin Endocrinol Metab 1982: 55: 434.
20. Koontz JW, Iwahashi M. Insulin as a potent, specific growth factor in a rat hepatoma cell line. Science 1981: 211: 947.
21. Stewart AJ, Johnson MD, May FEB, Westley BR. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 1990: 265: 21172.
22. Chen SC, Chon CK, Wong FH, Chang C, Hu C. Overexpression of epidermal growth factor and insulin-like growth factor I receptor and autocrine stimulation in human esophageal carcinoma cells. Cancer Res 1991: 51: 1893.
23. Bentley-Phillips C, Marks R. Cell division and metabolic activity of naevus cells. The relationships between anatomy and behaviour in males. Br J Dermatol 1976: 94: 557.
24. Baxter RC. The somatomedins: Insulin-like growth factors. Adv Clin Chem 1986: 25: 49.
25. Ellis DL, King LE, Nanney LB. Increased epidermal growth factor receptors in melanocytic lesions. J Am Acad Dermatol 1992: 27: 539.
26. Clemmons DR. Multiple hormones stimulate the production of somatomedin by cultured human fibroblasts. J Clin Endocrinol Metab 1984: 58: 850.
27. Fleming MG, Howe SF, Graf LH. Expression of insulin-like growth factor I (IGF-I) in nevi and melanomas. Am J Dermatopathol 1994: 16: 383.
28. Tavakkol A, Elder JT, Griffiths CEM, et al. Expression of growth hormone receptor, insulin-like growth factor I (IGF-I) and IGF-I receptor mRNA and proteins in human skin. J Invest Dermatol 1992: 99: 343.
29. Bourguignon J-P, Pierard GE, Ermould C, et al. Effects of human growth hormone therapy on melanocytic naevi. Lancet 1993: 341: 1505.
30. Gallagher RP, McLean DI, Yang CP, et al. Anatomic distribution of acquired melanocytic nevi: The Vancouver Mole Study. Arch Dermatol 1990: 126: 466.
31. Daughaday WH, Rotwein P. Insulin-like growth factor I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrinol Rev 1989: 10: 68.
32. LeRoith D, Clemmons D, Nissley D, Rechler MM. Insulin-like growth factors in health and disease. Ann Intern Med 1992: 116: 854.